Riskpilot← Back to searchSign inGet full accessDoktor.se Norrköping Vårdcentral AB
ABActiveOrg 5591164248NorrköpingGeneral medical practice activities · NACE 8621Est. 201729 employees
Revenue 2024
SEK 64,9M
+6% vs 2023
EBITDA margin
9.2%
+79% vs 2023
Equity ratio
53.8%
Financial strength
Net profit 2024
SEK 0
29 employees
| Revenue | SEK 64,9M | +6% |
| EBITDA | SEK 6M | +79% |
| Net profit | SEK 0 | — |
| Total assets | SEK 11,9M | -9% |
| Equity | SEK 6,4M | +0% |
| Employees | 29 | — |
Legal name
Doktor.se Norrköping Vårdcentral AB
Org number
5591164248
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 juni 2017
Share capital
SEK 50 000
Employees
29 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjuk- och hälsovård samt därmed förenlig verksamhet.
Address
Norrköping
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26 729 | 38 618 | 53 835 | 61 120 | 64 930 |
| Staff expenses | — | — | — | — | −27 804 |
| EBITDA | 937 | 6 750 | 5 184 | 3 332 | 5 977 |
| Depreciation & amort. | −100 | −154 | −221 | −231 | −206 |
| EBIT | 837 | 6 596 | 4 963 | 3 101 | 5 772 |
| Net financials | −1 | −4 | −5 | 2 | 5 |
| Profit before tax | 836 | 6 592 | −69 | 0 | 0 |
| Tax | −0 | −192 | −0 | −0 | — |
| Net profit | 836 | 6 400 | −69 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 754 | 10 464 | 11 666 | 13 037 | 11 885 |
| Equity | 913 | 6 463 | 6 394 | 6 394 | 6 394 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 841 | 4 001 | 5 272 | 6 643 | 5 491 |
| Total debt | 3 841 | 4 001 | 5 272 | 6 643 | 5 491 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
5.46×
This company
1.12×
Market median
+387% vs market
20202024
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JC Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2023 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doktorse Nordic AB
Doktor.se Norrköping Vårdcentral AB Board members of Doktor.se Norrköping Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Christian Andersson | Chief Auditor | 0 companies |
| André Kawmi | Deputy Board Member | 0 companies |
| Kais Abdulhussein Mahod | Board of Directors | 0 companies |
| Bo Martin Lindman | Board of Directors | 0 companies |
| Fadi Kawmi | Chairman | 0 companies |
| Anna Maria Gners Nivinger | Deputy Board Member | 0 companies |
| Martin Gösta Sellman | Deputy Board Member | 0 companies |